Literature DB >> 8518813

Dinucleotide repeat polymorphism mapping to the critical region for lissencephaly (17p13.3).

R Carrozzo1, D H Ledbetter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8518813     DOI: 10.1093/hmg/2.5.615

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


× No keyword cloud information.
  5 in total

1.  Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations.

Authors:  A Misra; P Chattopadhyay; A K Dinda; C Sarkar; A K Mahapatra; S E Hasnain; S Sinha
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Detecting deletions in the critical region for lissencephaly on 17p13.3 using fluorescent in situ hybridisation and a PCR assay identifying a dinucleotide repeat polymorphism.

Authors:  D T Pilz; A Dalton; A Long; T Jaspan; E L Maltby; O W Quarrell
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

3.  A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1.

Authors:  A K Godwin; L Vanderveer; D C Schultz; H T Lynch; D A Altomare; K H Buetow; M Daly; L A Getts; A Masny; N Rosenblum
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

4.  Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.

Authors:  D S Liscia; R Morizio; T Venesio; C Palenzona; M Donadio; R Callahan
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

5.  Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.

Authors:  T Takahashi; H Konishi; K Kozaki; H Osada; S Saji; T Takahashi; T Takahashi
Journal:  Jpn J Cancer Res       Date:  1998-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.